Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis
- PMID: 28442917
- PMCID: PMC5396978
- DOI: 10.2147/OTT.S130285
Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis
Abstract
Chemoradiotherapy is the most common treatment for inoperable esophageal cancer. However, there is no consensus on the delineation of the clinical target volume. Elective nodal irradiation (ENI) is recommended for inoperable esophageal cancer. A few studies have reported a decrease in the incidence of radiation-related toxicity of involved-field irradiation (IFI) for esophageal cancer. A systematic review and pooled analysis were performed to determine whether IFI in definitive chemoradiotherapy was more beneficial than ENI for esophageal cancer. The results showed no significant differences in the overall survival and local control rates between the IFI and ENI arms. Meanwhile, the incidences of esophageal and lung toxicities were significantly decreased in the IFI arm. These results suggest that IFI is a feasible treatment option for locally advanced esophageal cancer, especially to minimize irradiation-related toxicity.
Keywords: chemoradiotherapy; elective nodal irradiation; esophageal cancer; involved-field irradiation; meta-analysis.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures





Similar articles
-
Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.Curr Oncol. 2018 Oct;25(5):e423-e429. doi: 10.3747/co.25.3895. Epub 2018 Oct 31. Curr Oncol. 2018. PMID: 30464693 Free PMC article.
-
The role of involved field irradiation versus elective nodal irradiation in definitive radiotherapy or chemoradiotherapy for esophageal cancer- a systematic review and meta-analysis.Front Oncol. 2022 Nov 2;12:1034656. doi: 10.3389/fonc.2022.1034656. eCollection 2022. Front Oncol. 2022. PMID: 36408184 Free PMC article.
-
A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.Am J Clin Oncol. 2007 Jun;30(3):239-44. doi: 10.1097/01.coc.0000256691.27796.24. Am J Clin Oncol. 2007. PMID: 17551299 Clinical Trial.
-
Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis.Radiat Oncol. 2019 Oct 16;14(1):176. doi: 10.1186/s13014-019-1388-8. Radiat Oncol. 2019. PMID: 31619265 Free PMC article.
-
Involved field irradiation for the treatment of esophageal cancer: is it better than elective nodal irradiation?Cancer Lett. 2015 Feb 1;357(1):69-74. doi: 10.1016/j.canlet.2014.11.045. Epub 2014 Nov 24. Cancer Lett. 2015. PMID: 25464112 Review.
Cited by
-
Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis.Radiat Oncol. 2018 May 16;13(1):93. doi: 10.1186/s13014-018-1044-8. Radiat Oncol. 2018. PMID: 29769143 Free PMC article. Clinical Trial.
-
The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers-Review of the Literature.Cancers (Basel). 2023 May 29;15(11):2967. doi: 10.3390/cancers15112967. Cancers (Basel). 2023. PMID: 37296929 Free PMC article. Review.
-
Caution against simultaneous integrated boost radiotherapy for upper thoracic esophageal squamous cell carcinoma: results from a single-arm phase II trial.Esophagus. 2023 Oct;20(4):713-721. doi: 10.1007/s10388-023-01012-0. Epub 2023 May 7. Esophagus. 2023. PMID: 37149827 Clinical Trial.
-
Definitive Radiotherapy for Older Patients Aged ≥75 Years With Localized Esophageal Cancer.In Vivo. 2019 May-Jun;33(3):925-932. doi: 10.21873/invivo.11560. In Vivo. 2019. PMID: 31028218 Free PMC article.
-
Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients.Strahlenther Onkol. 2020 Sep;196(9):787-794. doi: 10.1007/s00066-020-01630-y. Epub 2020 May 19. Strahlenther Onkol. 2020. PMID: 32430661 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. - PubMed
-
- Paul S, Altorki N. Outcomes in the management of esophageal cancer. J Surg Oncol. 2014;110(5):599–610. - PubMed
-
- Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281(17):1623–1627. - PubMed
-
- Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167–1174. - PubMed
-
- Dai T, Shah MA. Chemoradiation in oesophageal cancer. Best Pract Res Clin Gastroenterol. 2015;29(1):193–209. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources